American International Group, Inc. Igm Biosciences, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.68 - $17.36 $477 - $954	-55 Reduced 0.83%	6,549 $63,000
Q4 2023 Feb 13, 2024	BUY	$3.94 - $8.79 $2,561 - $5,713	650 Added 10.92%	6,604 $54,000
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $1,411 - $2,255	212 Added 3.69%	5,954 $49,000
Q2 2023 Aug 04, 2023	BUY	$8.86 - $14.0 $5,634 - $8,904	636 Added 12.46%	5,742 $52,000
Q1 2023 May 12, 2023	BUY	$13.74 - $25.76 $1,401 - $2,627	102 Added 2.04%	5,106 $70,000
Q4 2022 Feb 10, 2023	SELL	$15.45 - $26.02 $293 - $494	-19 Reduced 0.38%	5,004 $85,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $5,227 - $9,156	339 Added 7.24%	5,023 $114,000
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $8,121 - $15,606	612 Added 15.03%	4,684 $84,000
Q1 2022 May 13, 2022	SELL	$13.42 - $29.73 $3,838 - $8,502	-286 Reduced 6.56%	4,072 $109,000
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $1,545 - $3,717	-56 Reduced 1.27%	4,358 $128,000
Q3 2021 Nov 12, 2021	SELL	$65.76 - $90.65 $6,904 - $9,518	-105 Reduced 2.32%	4,414 $290,000
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $8,986 - $14,973	155 Added 3.55%	4,519 $376,000
Q1 2021 May 07, 2021	BUY	$71.56 - $121.23 $17,102 - $28,973	239 Added 5.79%	4,364 $335,000
Q4 2020 Feb 12, 2021	SELL	$47.41 - $115.03 $5,689 - $13,803	-120 Reduced 2.83%	4,125 $364,000
Q3 2020 Nov 04, 2020	SELL	$43.0 - $84.01 $4,128 - $8,064	-96 Reduced 2.21%	4,245 $313,000
Q2 2020 Aug 12, 2020	BUY	$51.3 - $75.21 $72,333 - $106,046	1,410 Added 48.11%	4,341 $317,000
Q1 2020 May 04, 2020	SELL	$31.51 - $73.75 $5,388 - $12,611	-171 Reduced 5.51%	2,931 $165,000
Q4 2019 Feb 05, 2020	BUY	$17.25 - $49.51 $53,509 - $153,580	3,102 New	3,102 $118,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$30.3 Million
0.72% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.01M
Shares

$29.7 Million
0.01% of portfolio
Siren, L.L.C. New York, NY

3.33M
Shares

$24.6 Million
2.75% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$22.7 Million
3.32% of portfolio
Goldman Sachs Group Inc New York, NY

1.26M
Shares

$9.32 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $214M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account